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Abbreviations 
Ac  - acetyl 
ACG – acetogenin 
AKR – aminolytic kinetic resolution 
Bn - benzyl 
Boc - tert-butoxy carbonyl 
DCM - dichlorometane 
d.r – diastereomeric ratio 
cat. – catalyst 
Cbz -  benzyloxycarbonyl 
m-CPBA – meta-chloroperoxybenzoic acid  
eq. - equivalents 
e.r – enantiomeric ratio 
Et – Ethyl 
HKR – hydrokinetic resolution 
Me  - Methyl 
NMO – N-methylene morpholine oxide 
NMR – Nuclear magnetic resonance 
Nu – nucleophile 
PG – protecting group 
PMO – pyridine-N-oxide 
rt – room temperature 
TBAF – tetrabutylammonium fluoride 
THF – tetrahydrofuran 
THP – tetrahydropyran 
TLC – thin layer chromatography 
TPAP – tetrapropyl ammoniumperruthenate 
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Introduction 
In nature chirality plays a big role due to the different biological activity of enantiomers.  
Nearly all biological polymers have to be homochiral to function – either left handed as 
amino acids or right handed as sugars. Yet when synthesized in laboratory we mostly produce 
a racemic mixture of both enantiomers. While it is possible to separate enantiomers from each 
other it is often too expensive and difficult, and additionally, half of the material becomes 
useless. A more useful approach would be to synthesize only one isomer. Such approach is 
called asymmetric/stereoselective synthesis and it is the key step in modern chemistry to 
produce only the wanted enantiomer.  
Bis-tetrahydrofuran (THF) units, with four chiral centers (highlighted  in Figure 1), have been 
of great interest since they are the key unit of Annonaceus acetogenins. Acetogenins are 
naturally occurring compounds with broad spectrum of  biological activities such as 
cytotoxic, antitumor, antimicrobial, antimalarian, antifeedant, pesticidal, and 
immunosupressive effects.
1
 
. 
 
Figure 1. Acetogenins containing bis-THF rings. 
Due to difficulties to seperate these compounds from plant material and due to interesting 
biological properties, considerable effort has been made to synthesize acetogenins and their 
analogues. 
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The main purpose of this thesis was to develop a stereoselective synthesis route to such bis-
THF motifs. The main retrosynthetic steps are shown on Scheme 1. The key steps are 
stereoselective reduction of triple bond, kinetic resolution of bis-epoxide and oxidative 
cyclization.  
 
Scheme 1. Retrosynthetic scheme for the synthesis of bis-THF compounds. 
 
 
 
 
6 
 
Stereochemistry 
Stereochemistry describes how the atoms of a molecule are arranged in three-dimensional 
space. Many of the descriptions for stereogenic units begin with assigning priorities to the 
attached ligands, higher atomic number getting higher priority. There are various rules for 
assigning descriptors to stereocenters, here we provide a brief review of the terminology that 
is used in this thesis. 
R,S System – for tetracoordinated carbon and related structures the Cahn-Ingold-Prelog 
system is used. The center is termed R, if moving from the highest to the lowest priority 
ligands involves a clockwise direction. A counterclockwise direction implies S (Figure 2).  
 
Figure 2. Determing of S and R stereochemistry.  
E, Z System – For olefins and related structures the double bond is divided in half and two 
sides are compared. If the two high priority ligands are on the same side of the double bond, 
the system is Z; if they are on opposite sides, the system is E (Figure 3). If an H atom is on 
each carbon of the double bond, however, traditional „cis“ and „trans“ descriptors are used. 
 
Figure 3. Labeling alkene stereochemistry 
Erythro and Threo – This is the basis of a nomenclature system for compounds with two 
stereogenic centers. If the two stereogenic centers have two groups in common, erythro and 
threo terms can be assigned. If the groups that are the same are both on one side, the 
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compound is called erythro; if they are on opposite sides, the compound is called threo 
(Figure 4).
2
   
 
Figure 4. Determination of erythro and threo diastereomers. 
 
Acetogenins 
Annonaceus acetogenins (ACGs), a new class of polyketides, are natural products isolated 
exclusively from Annonaceae species that are wildely distributed in tropical and subtropical 
regions. Since uvaricin (Figure 5) was isolated in 1982
3
 from the roots of Uvaria accuminata, 
more than 400 members of this family of compounds have been isolated and characterized 
from 51 different species.
4,5
 
 
Figure 5. Uvaricin was the first Annonaceus acetogenin discovered. 
Much attention has also been paid to acetogenins’ broad range of bioactivity; e.g., their 
immunosuppressive, pesticidal, antimalarial, insecticidal, antifeedant, and probably most 
important, antitumor activities. In this respect they are known to be very potent cytotoxic 
compounds, targeting the reduced nicotinamide adenine dinucleotide (NADH) (also known as 
complex I). Some acetogenins show growth inhibitory activity against multidrug resistant 
(MDR) cancer cells. 
Chemically, the ACGs are white, waxy, derivatives of long unbranched aliphatic (C32 or C34) 
fatty acids that have been combined with a 2-propanol unit at C-2 to form a terminal methyl-
substituted α,β-unsaturated-γ-lactone ring. One, two, or three tetrahydrofuran (THF) or 
tetrahydropyran (THP) rings are located along the hydrocarbon chain and a number of 
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oxygenated moieties (hydroxyls, acetoxyls, ketones, epoxides) and double or triple bonds may 
be present.
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Figure 6.  Representative structure of the Annonaceous acetogenins. 
Generally, all ACGs belong to two broad groups:
7
  
1) classical ACGs, which involve ACGs comprising none to three THF units along with 
a terminal γ-lactone. 
2) Nonclassical ACGs, which incude ACGs containing a THP ring or hydroxylated THF 
ring along with a terminal γ-lactone. 
Due to the large number annonaceous acetogenins that have been isolated and characterised, a 
system of classification has been introduced, which groups them according to their core 
structure (Figure 7).7
,8 
These include mono-THF, adjacent bis-THF, nonadjacent bis-THF, tri-
THF, non-THF ring, adjacent THF and THP, non-adjacent THF and THP, mono-THP, and 
acetogenins containing only γ-lactones. 
 
Figure 7. Core units for classification of ACGs. 
The core classes can be broken down into sub classes by the nature of the γ-lactones, but 
commonly a methyl substituted α,β-unsaturated (butenolide) is present with or without 
hydroxylation in the linking chain.  
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All ACGs have multiple chiral centers. A number of them share the same skeleton and are 
differentiated from each other only by their stereochemistries around the THF subunits. In 
addition, the stereochemistries, in many cases, influence the relative potencies and biological 
specifities.
9
 The stereochemistry of ring systems leads to subclasses of acetogenins, and these 
subclasses are subsequently named after the first compound within that subclass to have its 
relative configuration determined. 
 
Figure 8. Six types of of adjecent bis-THF ring acetogenins.
10
  
Known synthetic routes to Rolliniastatin I type acetogenins 
The core unit of the adjacent bis-THF acetogenins contains six oxygenated stereocenters, and 
much of the synthetic work on the family has been focused on these stereocenters. Compared 
to other bis-THF ACGs, there have been very few successful syntheses of Rolliniastatin I type 
(Figure 9) ACGs reported.   
 
Figure 9.  Cytotoxic ACGs from seeds of Rollinia mucosa and R. membranacea. 
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First synthesis of rolliniastatin 1 was reported by Koert in 1994 who achieved this in 26 steps, 
starting with the enantiomerically pure cis-nitril (Scheme 2).
11 
 
Scheme 2. Synthesis of Rolliniastatin 1. 
First synthesis of membranacin was published by Brown’s group in 2004 where the bis-THF 
precursor was constructed from the lactone using metal-oxo and metal-peroxy-mediated 
oxidative cyclisations as the key steps. The butenolide portion of membranacin was 
introduced using Trost’s ruthenium-catalysed Alder-ene reaction (Scheme 3).12 
 
Scheme 3. Total synthesis of membranacin by Brown’s group. 
In 2005, Lee’s group also reported the total synthesis of membranacin, rolliniastatin 1 and 
rollimembrin (Scheme 4)
13
. First they synthesized bis-oxolane intermediate via radical 
cyclizations. This pivotal intermediate was used in a cross olefin methathesis reaction 
followed by the established three step sequence to finish the total synthesis of membranacin, 
rollimembrin and rolliniastatin.  
11 
 
 
Scheme 4. Total synthesis of membranacin, rolliniastatin 1 and rollinimembrin by Lee’s group. 
All of these synthetic routes are very long, in addition, their enantio- and diastereoselectivity 
is not very good. It is clear that they are not very effective, especially in larger scales, and 
better synthetic routes are needed. 
 
Literature review about the synthetic steps used in this work 
Alkyl-alkyne cross coupling 
Alkynes are an important class of organic compounds because they are frequently used as 
synthetic intermediates and precursors for natural products, biologically active molecules, and 
organic materials. The alkyl-alkynyl cross-coupling is among the most challenging coupling 
reactions and as a result, only a few methods are reported. These methods can be classified 
into four categories (Figure 10). 
The four main paths to an alkylated alkyne are: 1) Coupling of alkyl halides with terminal 
akynes under Sonogashira-type conditions (path A); 2) Palladium-catalyzed oxidative alkyl-
alkynyl coupling (path B); 3) Cross-coupling of alkynyl halides with organometallic alkyl 
reagents (path C). 4) Coupling of nonactivated  alkyl halides with alkynyl organometallic 
12 
 
reagents (path D). Only small number of protocols have been developed based on these 
reactions.
14 
 
Figure 10. Four types of transition-metal catalyzed cross-coupling methods for the synthesis of alkyl-
substituted alkynes. X – halide, M – metal. 
Epoxidation  
Epoxidation is an extremely valuable transformation in organic synthesis. Epoxides are highly 
reactive functional groups and their ring-opening allows the formation of a wide variety of 
substituted alcohol- and amine-containing compounds. 
Reaction of an alkene with an oxidizing agent, such as a peroxy-acid, leads to the formation 
of an epoxide ring. A number of peroxy-acids can be used, although the most common is 
meta-chloroperozybenzoic acid (mCPBA).
15
 Epoxidation of an alkene is a stereospecific 
reaction, with the geometry of the alkene retained.
 
 
 
Scheme 5. Epoxide formation via five-membered transition state.
16
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A selective reduction of alkynes 
Among alkynes’ most important applications is their selective reduction to (Z)-alkenes which 
is a reliable and highly useful synthetic method (Scheme 6). The catalyst most commonly 
used for this purpose – Lindlar catalyst - consists of  finely powdered palladium metal 
deposited on solid calcium carbonate that has been specially modified with lead salts.
17
 With 
the use of Lindlar catalyst the reduction slows down once the alkene has been formed, 
whereas the reaction with typical hydrogenation catalyst, such as Pd/C, the alkene is reduced 
all the way to the alkane.
18
 This reduction is very selective due to hydrogen adding to an 
alkyne to one side only. 
 
Scheme 6. Cis alkyne reduction by Lindlar catalyst. 
Trans addition of hydrogen to afford (E)-alkenes – the complementary process to cis 
reduction –  remains an elusive goal. One approach is a two-stage trans hydrometalation and 
subsequent protodemetalation reported by Trost et al
19
 in 2002. They discovered that the 
complex [Cp*Ru(MeCN)3]PF6 catalyzes the hydrosilylation of a wide variety of alkynes 
under mild conditions with good functional group tolerance and complete selectivity for the 
unusual trans addition. They coupled this transformation with a protodesilylation by the action 
of cuprous iodide and TBAF to achieve a two-step net trans reduction of alkynes (scheme 7). 
 
Scheme 7. Trans alkyne reduction by hydrosilylation-protodesilylation. 
Hydrolytic and aminolytic kinetic resolution of epoxides 
The hydrolytic kinetic resolution (HKR) of terminal mono-epoxides is a well-established 
method originally introduced by Jacobsen and co-workers.
20 
 In the presence of an activated 
chiral (salen)Co(III) catalyst and a nucleophile, one enantiomer of the racemic epoxide is 
opened by nucleophile to afford the enantiomerically enriched alcohol and the unreacted 
epoxide (Scheme 8). 
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Scheme 8. Kinetic resolution of terminal epoxides 
In case of terminal bis-epoxides (Scheme 9) the situation is slightly different, as it consists of 
three isomers: RS (meso), RR, and SS. The meso isomer is expected to be resolved to afford 
up to 50% yield, while the other two isomers yield diol and unreacted bis-epoxide, 
respectively. Few studies have examined bis-epoxides as substrates in kinetic resolution 
reactions.  
 
Scheme 9. Kinetic resolution of bis-epoxides 
In 2013, our research group
21
 reported the first HKR of aromatic bis-epoxides and the 
aminolytic kinetic resolution (AKR) of bis-epoxides, along with HKR of aliphatic bis-
epoxides catalyzed by chiral(salen)-Co
III 
complexes. An efficient use of Jacobsen’s catalyst  
for the highly enantio- and diastereoselective synthesis of epoxy-diols and N-protected epoxy-
amino alcohols was reported (Scheme 10).  
 
Scheme 10. HKR and AKR of bis-epoxides 
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Oxidative cyclization in synthesis of enantiomerically pure THFs 
The oxidative cyclization of 1,5-dienes to form the corresponding 2,5-disubstituted THFs has 
been known for almost 50 years and was first disclosed by Klein and Rojhan in 1965 via the 
use of stoichiometric KMnO4.
22 
Since this initial report a variety of other metal-oxo species 
have been shown to accomplish this transformation with varying degrees of competency. A 
significant improvement to the methology has been made with the realisation that vicinal 
diols, generated from 1,5-dienes, will form the THF products when subjected to oxidative 
cyclization conditions with controlled stereoselectivity. 
Donohoe and Butterworth developed a novel catalytic process that enables the controlled 
synthesis of five-membered heterocycles promoted by osmium (Scheme 11). They used PMO 
as a reoxidant for osmium to oxidize Os(IV) to Os(VI) (this being the more active catalyst for 
the cyclization process) but not to unwanted Os(VIII) – which can result in the 
dihydroxylation of the starting material.
23,24
 In addition, Os(VI) species are significantly less 
toxic than Os(VII) species.  
 
Scheme 11. Osmium-catalyzed oxidative cyclization for the diastereoselective synthesis of cis-THFs. 
They also discovered that a greater variety of chelating functionality (other than 1,2-diols) 
would be able to condense with Os
VI
 and subsequently cyclize to form a wider range of 
heterocyclic motifs. Exchanging the hydroxyl group at the tris-homoallylic position for a 
suitable nitrogen-containing substituent allowed the synthesis of a range of THFs flanked with 
amide, sulfonamide or carbamate functionality in good to excellent yields (Scheme 12).
25
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Scheme 12. Synthesis of amide, sulfonamide, and carbamate-flanked THFs. 
Stark and Cheng presented a new catalytic method for the stereocontrolled oxidative 
cyclization of 5,6-dihydroxy alkenes to yield THF-diols in high diastereo- and enantiopurity 
using ruthenium(VII) catalyst (Scheme 13).
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Scheme 13. Ruthenium-catalyzed oxidative cyclization of 5,6-dihydroxy alkenes.  
They tested a set of mild ruthenium-based oxidants under different reaction conditions for 
their ability to promote the selective oxidative cyclization of 5,6-dihydroxy alkenes and found 
that TPAP (tetrapropylamonium perruthenate), one of the mildest catalysts tested, provided 
the desired cyclization product in good yield. By using N-methylmorpholine-N-oxide (NMO) 
as a reoxidant for ruthenium (from Ru(V) back to initial active Ru(VII)) smooth ring 
formation took place while reaction conditions remained extraordinarily mild.   
 
. 
  
17 
 
Results and discussion 
The aim of this study was to develop a short, efficient, stereochemically flexible and 
asymmetric route for the synthesize of bis-THF units (Scheme 14).  
 
Scheme 14. Devised synthesis route.   
The initial plan was focused on the synthesis of core structure 5 as a key motif for bis-THF 
ring formations. Symmetric alkyne 2 with terminal double bonds was prepared from 1 via 
alkyne-alkyle cross coupling reaction, followed by epoxidation of double bonds to give bis-
epoxide 3. Compound 3 was then selectively reduced to trans-alkene 4 or cis-alkene 8. These 
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alkenes were used in kinetic resolution reactions giving compounds  5 and 9, respectively.  
Then oxidative cyclization was used on these compounds to get compounds 6 and 10, 
followed by Sn2 cyclization to form bis-THF compounds 7 and 11.  
Alkyle-alkyne cross coupling 
 
Scheme 15. Preparation of compound 2. 
No exact method is given in literature for prepering this compound other than a note in a 
paper by Hopf and Kirsch.
27
 At first, the experiment was carried out in unhydrous THF as in 
the literature, but it caused the Grignard reagent to turn grey in color and some percipitation 
was observed even before addition of alkyne. Because the allylmagnesium bromide was 
already in ether solution it was decided to leave out THF and carry out the reaction with no 
additional solvent. Another consideration was reaction time. In test runs it was found out that 
few hours was not enough for allyl groups to react completely so the reaction was usually 
carried out overnight. Byproduct of this reaction has very similar polarity with the product 
which made purification by column-chromatography problematic. Distillation, as an 
alternative purification method, did not afford better results. Recieved yield was 67% 
(impurity 2%, determined by NMR), which was 16% higher than the Hopf and Kirch had 
reported and the spectral data was in a good correspondence with the values given in the 
article. 
Epoxidation of terminal alkenes. 
 
Scheme 16. Epoxidation of diene. 
It was anticipated that this reaction would go smoothly because similar reactions, although 
without a triple bond, had been investigated extensively in our labarotory with no issues. We 
unexpectedly experienced problems with the low yield, and although we were able to improve 
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it, the yield remained unsatisfactory. Many different reaction conditions were tested – reaction 
was carried-out at room temperature and in an ice bath, reaction time was varied from few a 
hours to overnight, and amount of mCPBA was varied from 2 eq to 3,5 eq. One of the 
proposed reasons for low conversion was that the triple bond could be acid sensitive and 
decomposes when m-chlorobenzoic acid is produced as byproduct and therefore two phased 
system should be used;
28
 that allows the product 3 to stay in organic phase and m-
chlorobenzoic acid goes into aqueus bicarbonate phase. This method did not work and 
gathered yield was even worse than by single solvent system. It was determined by TLC that 
the starting material was easily converted into intermediate, where one alkene is epoxidized. 
The problem occurs with the conversion from this intermediate to the desired product. We 
speculated that this could be due to the lack mCPBA, but increasing the amount of mCPBA to 
3.5 eq improved the yield only slightly. After purification process, we treated our unreacted 
intermediate with an additional amount of mCPBA. However, we could observe that many 
undesired byproducts formed in this step; and that the reaction had completed and no 
intermediate was observed by TLC.   
Alkyne reduction to (E)-alkene 
 
Scheme 17. Trans reduction by different silanes. 
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There are limited options for trans-alkene reduction in literature with high yields so we were 
very pleased to find a method by Trost group19 that promised fairly good yields for 
compounds similar to ours. This is a two step process (Scheme 17) and for the first step we 
precisely followed the procedure given in the article and it went rather smoothly; the biggest 
complication was desilylation step, which was the main reason for very low yield of 22%. We 
varied the amount of CuI used, reaction times and temperature, however none of these 
changes resulted in improved yield. In  addition, a high amount of CuI probably lead to 
epoxide ring opening in purification step, which made the handling of crude product very 
problematic. 
Due to the complications and low yields of compound 4 we tested conditions reported by 
Fürster’s29 group. As they also had problems with desilylation step using Trost’s original 
method, they tested different silane and found benzyldimethylsilane to afford faster and 
smoother conversion in both steps. We tested Fürster’s silane and we were pleased that the 
silylation proccess improved significantly and we could even reduce the amount of catalyst 
from 10 mol% to 5 mol%. However, reducing the catalyst loading increased the reaction time 
from half an hour to 2.5 hours, but there was no reduction in yield. The removal of the silyl 
group was faster, although not as fast as we had hoped. The desilylation process still had to be 
carried out overnight, but at room temperature and without the need for CuI at all.  With these 
slight modifications in reaction times and catalyst amount very high yields were obtained. No 
trace of (Z)-alkene product was observed by 1H NMR analysis, which can also be expected 
based on Trost’s and Fürster’s works. 
Alkyne reduction to (Z)-alkene 
 
Scheme 18.  Alkyne reduction with Lindlar catalyst 
Cis-reduction using Lindlar catalyst was very effective on our alkyne 3. Reaction went 
smoothly and according to NMR spectra from crude reaction mixture the conversion to 
compound 8 was complete and no starting material nor trans-alkene was observed.  Lindlar 
catalyst was filtered out, but no additional purification was done. 
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Kinetic resolution of bis-epoxide  
 
Scheme 19. HKR of (E)-bis-epoxide. 
The bis-epoxide 4 used in the synthetic route consists of three isomers: 50% of the meso 
isomer (R,S), 25% of (S,S)-isomer and 25% of (R,R)-isomer. We subjected this isomeric 
mixture to HKR with the activated (S,S)-(salen)Co(III)OAc catalyst and used 1.05 eq H2O as 
nucleophile. This reaction has been extensively studied in our labratory and we expected it to 
go smoothly. Our target product was the epoxy-diol 5a from the meso isomer (R,S). 
Fortunately, we had no problems with this conversion and it was also successfully separated 
on column chromatography after HKR to afford product in 41% yield (maximum yield being 
50%).  
 
Scheme 20. HKR of (Z)-bis-epoxide. 
We kept the reaction conditions the same as HKR on (E)-bis-epoxide. As expected, this 
reaction went very well when applied to (Z)-bis-epoxide 8.  
 
 
Scheme 21. AKR of (E)-bis-epoxide. 
We also tested aminolytic kinetic resolution with our bis-epoxide 4. Reaction conditions 
stayed similar as before but instead of H2O as a nucleophile NH2Boc was used. According to 
the TLC analysis the conversion went smoothly. Unfortunately, technical problem occurred in 
purification step and some of the material was lost. We could isolate the pure product with 
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only 17% yield (maximum yield being 50%), however, we have reason to believe, that with 
more careful purification significantly better yields can be achieved. 
Enantiomeric and diastereomeric purity of kinetic resolution products was not measured, but 
based on previous results in our laboratory with related substrates, we could expect high e.r 
and d.r. It is important to note, that the use of opposite catalyst isomer would result the 
formation of opposite product enantiomer. 
Oxidative cyclization by ruthenium catalyst and addition of protection 
group 
 
Scheme 22. Cyclization of 5a with Ru-catalyst. 
We then focused on the formation of THF-ring via oxidative cyclization catalyzed by 
ruthenium. Our first attempts followed protocol reported by Stark
25
 group. Unfortunately this 
reaction proved to be inefficient under these reaction conditions. The reaction course was hard 
to observe by TLC because it was impossible to see product formation as it has very similar 
polarity as compound 6a. Because we had difficulties to determine if the reaction had 
completed, most reactions were carried out for 24 hours at room temperature. Our first test 
reaction with wet CH2Cl2 as a solvent gave at best ca 30% conversion. We were encouraged 
to see, that the cyclization strategy works, albeit with modest yield. We made several attempts 
to increase yield with some extra H2O, as it had helped in some cyclization processes. We 
also switched solvent to tert-butanol. Unfortunately our efforts did not improve the yield and 
in most cases no product was observed in crude mixture.  
This transformation was then investigated more closely and some test reactions were run in a 
NMR tube with deuterated chloroform as a solvent. This allowed us to monitor this reaction 
by taking 
1
H spectra hourly and 
13
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spectra every 2-4 hours during the night. We were happy 
to observe better conversion in which the ration of cyclisized product and starting material 
was up to 2:1 based on integration of different signals in 
1
H NMR spectra. We also noticed 
that the conversion was in fact fast as opposed to our belief that it is a sluggish reaction; in 
fact, most of conversion happened in first 10 minutes and then slowly stopped until after 2 
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hours no further conversion was observed. We were also concerned that a second cyclization 
might occur in situ but this was not observed. We then added another catalytic amount of 
TPAP catalyst and NMO in hope it would further improve the conversion, however, this did 
not have any effect.  
We then transfered the conditions developed in NMR tube to the reaction flask and tried to 
scale up the reaction. Unfortunately though,  the conversion was not as good as in the NMR 
tube and we observed ca 1:1 ration of starting material and product. As it was still better than 
our initial attempts we went on and tried to purify the crude product. As before, we were 
unable to efficiantly separate starting material from the product. We also observed several 
byproducts in this reaction that possibly indicate decomposition and/or further cyclization of 
our product in purification step.  
 
Scheme 23. Cyclization of 9 with Ru-catalyst.  
Same NMR tube reaction conditions were applied to cis-compound 9 and monitored over 12 h 
period. The conversion to compound 10 was only minimal ca 10% based on integration of 
different signals in 
1
H NMR spectra. We noticed that the conversion was happening only in 
the first minutes and then stopped completely. Addition of TPAP and NMO had no effects on 
conversion, same as we observed in our reactions with trans-compound 5. 
 
 
Figure 11. Symmetrical bis-THF units for cis and trans compounds. 
Next, we attempted to protect the primary hydroxyl of 6a since otherwise the second 
cyclization would lead to a symmetrical bis-THF unit (Figure 11). Suitable protecting strategy 
was needed, which would not affect other functional groups and would not cause the second 
cyclization before the protection group was in place. Therefore very mild conditions were 
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needed as strongly acidic/basic conditions were known to initiate a second cyclization 
process.  
The first protecting group we considered using was tert-butyldiphenylchlorosilane. 
Unfortunately it initiated the second cyclization process and an undesired symmetric molecule 
was obtained.   
We kept exploring for methods that would suit us and to our delight we found one method 
that seemed appropriate. This method was based on Copper(I)/TEMPO-catalyzed aerobic 
oxidation of primary alcohols to aldehydes with ambient air.
30
 We were very excited about 
this finding as the method is simple, selective and has mild reaction conditions with fairly 
high yields. In addition, there is very high selectivity promised for the oxidation of primary 
alcohols in the presence of secondary alcohols, allowing for the selective oxidation of 
unprotected diols. This gave us hope that this method would work perfectly for our 
compound. Unfortunately no oxidation was observed in room temperature using both 
catalysts suggested in the article. 
This method was then applied on more simple alcohols, to make sure the general method 
works. 1,2-diols were also tested because we considered the possibility of adding protecting 
group before the first cyclization step. On linear simple primary alcohols this method works 
very well, but despite our efforts 1,2-diol remained still unreactive.   
During our work we discovered that conversions were generally low, and in addition the 
protection of primary hydroxyl group remained challenging. Due to these reasons we began 
looking for alternative methods for our synthesis route. 
Oxidative cyclization with osmium catalyst 
 
Scheme 24. Cyclization of 9 with Os-catalyst 
We first applied this reaction on compound 9. As this reaction had minimal conversion with 
ruthenium catalyst we were interested to test if it improved with osmium catalyst. The 
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reaction was carried out in deuterated solvents to allow us to take NMR. 
1
H data was recorded 
hourly for first few hours and then after 24h. It was immediately observed that the conversion 
was a lot better this time. We were worried that heating might open our epoxide and second 
cyclisation would occur, but it did not happen and even after 24h epoxide was intact. The 
second cyclization did occurred on work-up step, but it is clear that this could be avoided.  
 
Scheme 22. Cyclization of 5b with Os-catalyst. 
This reaction was then applied to compound 5b with deuterated solvents to monitor its course 
by measuring 
1
H spectra hourly. Very good conversion was observed and, after 5 hours of 
heating at 60 degrees, the ratio of starting material to product was ca 1:4 based on integretion 
of relevant signals in 
1
H NMR spectra. As compound 5b has already NHBoc instead of 
primary OH, we were not concerned about the second cyclization happening at this point, but 
none was observed. The second cyclization could likely be initiated in work-up process 
making it an excellent one-pot reaction.    
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Conclusion 
In this work a stereoselective and effective synthetic route for bis-THF unit has been 
developed.  
Bis-THF units are key motifs for acetogenins that have broad range of bioactivities, most 
prominent of them being cytotoxic against cancer cells. Considerable effort has been made to 
synthesize acetogenins and its analogues because the seperation of these compounds from 
plant material is difficult and inefficient. Prior to this work, the synthetic routes for 
Rolliniastatin I type of acetogenins were long and with poor enantio- and diastereoselectivity, 
which made them inefficient, particularly in larger scales. In our developed method the 
synthetic route is significantly shorter, involving only 5 main steps, starting with easily 
accessible starting material, and offering excellent enantio- and diastereoselectivity. The key 
steps are selective reduction of alkyne, kinetic resolution of bis-epoxide and oxidative 
cyclization, making it short, efficient, stereochemically flexible, and highly asymmetric route 
for bis-THF units.   
In the experimental section we proved that this synthesis is indeed possible and the key steps 
resulted target products in good yields. This is an important breakthrough in the synthesis of 
bis-THF units and for the synthesis of Rolliniastatin I type acetogenins in general. 
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Bis-tetrahüdrofuraani ühendite stereoselektiivne süntees 
 
Kokkuvõte 
Antud töös on välja töötatud stereoselektiivne ja efektiivne sünteesitee bis-THF fragmendi 
sünteesiks. 
Bis-THF fragmendid on tähtsaimaks struktuuriüksuseks atsetogeniinides, mis on väga 
huvipakkuvad oma bioloogiliste omaduste poolest. Neist kõige silmapaistvam on 
atsetogeniinide tsütotoksiline toime erinevatele vähirakkudele. Märkimisväärseid pingutusi on 
tehtud atsetogeniinide ja nende analoogide sünteesis, kuna puhaste atsetogeniinide eraldamine 
looduslikest taimeekstraktidest on keeruline ja kulukas.  Seni raporteeritud bis-THF 
fragmendi sünteesiteed, näiteks Rolliniastatin I tüüpi atsetogeniinideks, on pikad ja kehva 
enantio- ja diastereoselektiivsusega. See teeb nende sünteesi, eelkõige suures skaalas, 
ebaefektiivseks. Meie väljatöötatud sünteesitee on oluliselt lühem, koosnedes vaid viiest 
põhilisest etapist, alustades lihtsalt kättesaadava lähteühendiga ning võimaldab suurepärast 
enantio- ja diastereoselektiivsust. Olulisemad etapid koosnevad alküüni selektiivsest 
taandamisest, bis-epoksiidi kineetilisest lahutamisest ja oksüdatiivsest tsükliseerimisest. 
Sünteesitee on lühike, tõhus, stereokeemiliselt paindlik ja äärmiselt asümmeetriline moodus 
bis-THF fragmendi sünteesiks. 
Eksperimentaalses osas me kinnitasime, et antud sünteesitee toimib ja näitasime, et põhietapid 
andsid soovitud ühendid väga heade saagistega. Tegemist on olulise läbimurdega bis-THF 
ühendite sünteesides ja Rolliniastatin I tüüpi atsetogeniinide sünteesis üldisemalt.  
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Experimental part 
General 
All commercially available chemicals were of reagent grade and used without further 
purification; Flash-column chromatography was performed on silica gel 230-400 mesh or on 
Isolera One with GraceResolv cartridges. TLC was performed using Macherey-Nagel silica 
gel plates „Alugram® Sil G/UV 254“. Spots were visualized by UV light at 254 nm or by 3% 
PMA in ethanolic solution with subsequent heating. NMR spectra were obtained on a Bruker 
AVANCE II 400 instrument at 400.1 MHz for 
1
H and 100.6 MHz for 
13
C at the Institute of 
Technology, University of Tartu. The chemical shifts are reported in ppm using CDCl3 signals 
(
1
H at 7.26 ppm; 
13
C at 77.0 ppm) as reference unless stated otherwise. Coupling constants (J) 
are reported in herz (Hz).  
Synthesized compounds 
1,9-decadiene-5-yne (2) 
To allylmagnesium bromide solution 1.0 M in diethyl ether (50 mL, 50 mmol) under an Ar 
atmosphere was added dropwise 1,4-dichloro-2-butyne (2 mL, 20 mmol) over 20 min. The 
reaction mixture was stirred and, when neccessary, cooled in an ice bath when ether began 
boiling too rapidly (occured only during the first 30 min after addition of alkyne). After 50 
min mixture turned from brown color to dark grey and slowly some precipitation appeared 
and after another 20 min there was a lot of thick light grey precipitation. The reaction was left 
to stir overnight, cooled to 0 C and quenched by addition of NH4Cl (saturated aqueous). This 
was followed by filtration and extraction with additional amount of NH4Cl. Organic layer was 
then washed with brine, dried over Mg2SO4, filtrated, concentrated (at 150 mbar, 40 C), and 
purified by flash chromotography to afford 1.8 g (67%) of the desired compound 2 as 
colorless liquid.  
1
H NMR (400.1 MHz, CDCl3):  5.8-5.9 (m, 2H), 4.99-5.08 (m, 4H), 2.21-
2.26 (m, 8H). 
13
C NMR (100.6 MHz, CDCl3):  137.2, 115.2, 33.3, 18.6. 
1,6-di(oxiran-2-yl)hex-3-yne (3) 
To 0.3 M solution of 1,9-decadiene-5-yne 2 (1.8 g, 13.4 mmol) in DCM  was added mCPBA 
(9.022 g, 40.25 mmol, 3 eq) in an ice bath. After 1 hour the ice bath was removed and 
reaction mixture was stirred for another 3 h at rt. The solution was a milky slurry at this point. 
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Because TLC analysis still showed some incomplete conversion an additional 0.5 g of 
mCPBA was added.  After 1 hour reaction mixture was filtered through the plug of cotton and 
extracted with Na2CO3 (saturated aqueous) and concentrated under reduced pressure. To 
further remove m-chlorobenzoic acid (byproduct), the impure product was dissolved in 
EtOAc and extracted twice with aqueous Na2CO3. Organic layer was then dried over Mg2SO4, 
filtered, and concentrated to dryness in vacuo. The crude product was purified by flash 
chromotography to afford 935.8 mg (42%) desired bis-epoxide compound 3 as pale yellow 
oil. 
1
H NMR (400.1 MHz, CDCl3):  2.99-3.08 (dddd, 2H), 2.77-2.82 (dd, 1H), 2.5-2.54 (m, 
1H), 2.30-2.37 (m, 1H), 1.73-1.82 (m, 1H), 1.6-1.72 (m, 1H). 
13
C NMR (100.6 MHz, CDCl3): 
 79.6, 51.3, 47.0, 32.0, 15.5. HRMS (ESI): calcd for C10H14O2 [M + Na]
+  
189.0886, found 
189.0886. 
(E)-1,6-di(oxiran-2-yl)hex-3-ene (4) 
To 0.5 M solution of bis-epoxide 3 (353.8 mg, 2.1 mmol) in DCM under an Ar atmosphere 
was added benzyldimethylsilane (498 µL, 3.15 mmol). Cp*Ru(MeCN)3]PF6 (53.7 mg, 0.1 
mmol) was added after cooling the flask in an ice bath. After the catalyst was fully dissolved 
the flask was allowed to warm to ambient temperature, where it was stirred for 2 h. At this 
point TLC control indicated complete conversion. The solution was diluted in ether (5 mL), 
filtered through a plug of florisil (1 cm), and washed with additional ether (20 mL). The 
filtrate was concentrated under reduced pressure (15 mbar, 25 C) and taken up in THF (2.8 
mL) under Ar and cooled in an ice bath. A solution of anhydrous TBAF 1 M in THF (4.9 mL, 
4.9 mmol) was then added dropwise and resulting orange mixture was stirred at rt overnight. 
The dark brown crude product was purified by flash chromotography to afford 278 mg (79%) 
of product 4. 
1
H NMR (400.1 MHz, CDCl3):  5.51 (s, 1H), 2.93 (bs, 2H), 2.76 (s, 2H), 2.46-
2.49 (m, 2H), 2.8 (bs, 3H), 1.55-1.64 (m, 3H). 
13
C NMR (100.6 MHz, CDCl3): . 129.9, 51.8, 
47.1, 32.4, 28.9. HRMS (ESI): calcd for C10H16O2 [M + Na]
+  
191.1043, found 191.1040. 
(R,E)-8-((S)-oxiran-2-yl)oct-5-ene-1,2-diol (5a) 
To 0.05 M solution of (S,S)-(salen)Co
II
 complex (16.2 mg, 26.8 µmol) in DCM AcOH (3 µL, 
53.6 µmol) was added. The mixture was stirred at room temperature and open to air for 30 
min, during which time the color turned from dark red to brown. Then the solution was 
concentrated to dryness in vacuo. The crude solid was dissolved in 0.3 mL dry THF and 
added to bis-epoxide 4 (116.4 mg, 0.69 mmol). Then H2O was added (13.1 µL, 0.72 mmol) 
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and reaction was stirred over the weekend at room temperature. Solvent was removed in 
vacuo and  the product 5a was isolated by flash chromatography as a bright yellow oil (53.2 
mg, 41%).
1
H NMR (400.1 MHz, CDCl3):  5.46 (m, 2H), 3.56-3.72 (m, 2H), 3.37-3.43 (m, 
1H), 2,9 (bs, 2H), 2,73 (dd, 1H), 2,47 (dd, 1H), 2.02-2.21 (m, 4H), 1.4-1.67 (m. 4H). 
13
C 
NMR (100.6 MHz, CDCl3): . 130.4, 129.8, 71.7, 66.7, 52.0, 47.1, 32.7, 32.4, 29.0, 28.6. 
tert-butyl ((R,E)-2-hydroxy-8-((S)-oxiran-2-yl)oct-5-en-1-yl)carbamate (5b) 
To 0.05 M solution of (S,S)-(salen)Co
II
 complex (19.7 mg, 32.6 µmol) in DCM was added 
AcOH (3.7 µL, 65.2 µmol). The mixture was stirred at room temperature open to air for 30 
min, during which time the color turned from dark red to brown. Then the solution was 
concentrated to dryness in vacuo. The crude solid was redissolved in 0.3 mL dry THF and 
added to bis-epoxide 4 (150 mg, 0.8 mmol). Then NH2Boc was added (105 mg, 0.9 mmol) 
and reaction was stirred over night at room temperature. Solvent was removed in vacuo and 
the product 5b was isolated by flash chromatography as pale yellow oil (42.1 mg, 17%). 
1
H 
NMR (400.1 MHz, CDCl3):   5.46 (dt, J=5Hz, 2H), 5 (bs, 1H), 3.67 (bs, 1H), 3.23-3.29 (m, 
1H), 2.89 (dd, J= 3.3, 1.8, 1H), 2.73 (dd, J= 4.8, 4, 1H), 2.47 (dd, J= 5, 2.8, 1H), 2.04-2.18 (m, 
4H), 1.4-1.65 (m. 14H). 
13
C NMR (100.6 MHz, CDCl3):  156.8, 130.4, 129.8, 79.5, 71.0, 
52.0, 47.1, 46.6, 34.3, 32.4, 29.0, 28.6, 28.4. 
(S)-1-((2S,5R)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3-((S)-oxiran-2-yl)propan-1-ol 
(6a) 
A 0.5 M solution of the diol 5a (21 mg, 0.113 mmol) in DCM (2.26 ml) was treated with 
NMO (19.4 mg, 0.143 mmol, 1.2 eq), followed by TPAP (2 mg, 5.64 µmol, 5 mol%). The 
reaction progress could not be monitored by TLC as the product and starting material had too 
similar polarities. After 24 h the reaction mixture was concentrated under reduced pressure 
(25 C, 0 mbar). Resulting crude product was purified by column chromatography and gave 
compound 6a (7 mg, ca 30%) with some impurities. 
1
H NMR (400.1 MHz, CDCl3):  4.05- 
4.17 (m, 2H), 3.82-3.87 (m, 2H), 3.48-3.53 (m, 2H), 2.95-3.0 (m, 1H), 2.77 (m, 1H), 1.65 (m, 
6H). 
13
C NMR (100.6 MHz, CDCl3):  82.8, 79.9, 73.7, 65.1, 52.0, 47.3, 30.1, 28.5, 27.2. 
HRMS (ESI): calcd for C10H18O4 [M + H]
+  
203.1277, found 203.1277. 
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tert-butyl(((2R,5S)-5-((S)-1-hydroxy-3-((S)-oxiran-2-yl)propyl)tetrahydrofuran-2-yl)- 
methyl)carbamate (6b) 
This compound was synthesized by a literature procedure.
31
 To a solution of compound 5b 
(24.2 mg, 78.8 µmol) in CD3CN (958 µL) and D2O (639 µL) PNO (30.6 mg, 0.16 mmol), 
citric acid (11.5 mg, 60 µmol), K2OSO4·H2O (0.6 mg, 1.6 µmol) and Zn(OTf)3 (14.5 mg, 40 
µmol) were added. The resulting solution was warmed to 60 C and the product 6b formation 
was monitored by 
1
H NMR. 
1
H NMR (400.1 MHz, CDCl3):  3.93- 4.02 (m, 2H), 3.73-3.8 
(m, 2H), 3.55 (d, J= 3.8, 2H), 2.95-3.0 (m, 1H), 2.77 (m, 1H), 1.65 (m, 2H), 1.37 (s, 17H).  
(Z)-1,6-di(oxiran-2-yl)hex-3-ene (8) 
Quinoline (2.226 ml of a stock solution [1:500 quinoline/hexane] and alkyne 3 (249 mg, 1.5 
mmol) were dissolved in hexane/EtOH ( 10 mL, 1:1). Lindlar catalyst (304 mg, 0.15 mmol) 
was added and the resulting suspension was stirred for 30 min under an atmosphere of H2 (1 
atm). The catalyst was filtered off through a pad of Celite, the solvent was evaporated. 
Product 8 yield was considered to be 100% and was not purified any futher. 
1
H NMR (400.1 
MHz, CDCl3):  5.38-5.46 (m, 2H), 2.93 (bs, 2H), 2.76 (s, 2H), 2.46-2.49 (m, 2H), 2.21 (m, 
4H), 1.55-1.64 (m, 3H). 
13
C NMR (100.6 MHz, CDCl3): . 129.3, 58.3, 51.9, 47.1, 32.4, 23.7, 
18.4. HRMS (ESI): calcd for C10H16O2 [M + Na]
+  
191.10425, found 191.1037. 
(R,Z)-8-((S)-oxiran-2-yl)oct-5-ene-1,2-diol (9) 
To 0.05 M solution of (S,S)-(salen)Co
II
 complex (36.2 mg, 60 µmol) in DCM AcOH (6.8 µL, 
120 µmol) was added. The mixture was stirred at room temperature and open to air for 30 
min, during which time the color turned from dark red to brown. Then the solution was 
concentrated to dryness in vacuo. The crude solid was redissolved in 0.7 mL of dry THF and 
added to bis-epoxide 8 (252 mg, 1.5 mmol). Then H2O was added (28.3 µL, 1.57 mmol) and 
reaction was stirred over the weekend at room temperature. Solvent was removed in vacuo 
and the product 9 was isolated by flash chromatography as pale yellow oil (80.9 mg, 29%). 
1
H 
NMR (400.1 MHz, CDCl3):   5.41 (m, 2H), 3.7-3.75 (m, 1H), 3.38-3.44 (m, 1H), 2.93 (dd, 
J= 4.3, 2.8, 2H), 2.77 (m, 2H), 2.5 (dd, J= 4.9, 2.9, 1H), 2.13-2.28 (m, 4H). 
13
C NMR (100.6 
MHz, CDCl3):  130.1, 129.1, 71.6, 67.9, 52.0, 47.4, 32.8, 32.3, 25.6, 23.7. 
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(R)-1-((2S,5R)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3-((S)-oxiran-2-yl)propan-1-ol 
(10) 
A 0.5 M solution of the diol 9 (13.8 mg, 74.2 µmol) in CDCl3 (1.5 ml) was treated with NMO 
(12 mg, 89 µmol, 1.2 eq), followed by TPAP (2.6 mg, 7.4 µmol, 10 mol%). The resulting 
solution was monitored by 
1
H NMR.  
(R)-1-((2S,5R)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3-((S)-oxiran-2-yl)propan-1-ol 
(10) 
This compound was synthesized by a literature procedure.
32
 To a solution of compound 9 
(10.6 mg, 57 µmol) in CD3CN (420 µL) and D2O (280 µL) was added PNO (10.8 mg, 0.11 
mmol), citric acid (8.2 mg, 42.7 µmol), K2OSO4·H2O (0.4 mg, 1.1 µmol) and Zn(OTf)3 (10.4 
mg, 28.4 µmol). The resulting solution was warmed to 60 C and the product 10 formation 
was monitored by 
1
H NMR. 
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Figure 12. Compound 2 
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Figure 13. Compound 2 
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C spectra 
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Figure 14. Compound 3 
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H spectra 
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Figure 15. Compound 3 
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Figure 16. Compound 4 
1
H spectra 
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Figure 17. Compound 4 
13
C spectra 
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Figure 18.  Compound 5a 
1
H spectra 
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Figure 19. Compound 5a 
13
C spectra  
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Figure 20. Compound 5b 
1
H spectra 
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Figure 21. Compound 5b 
13
C spectra 
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Figure 22. Compound 6a 
1
H spectra 
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Figure 23. Compound 6a 
13
C spectra 
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Figure 24. Compound 6b 
1
H spectra 
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Figure 25. Compound 8 
1
H spectra  
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Figure 26. Compound 8 
13
C spectra  
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Figure 27. Compound 9 
1
H spectra 
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Figure 28. Compound 9 
13
C spectra 
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